Overview

EPAT: Estrogen in the Prevention of Atherosclerosis Trial

Status:
Completed
Trial end date:
1998-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of estrogen replacement therapy (ERT) on the progression of early atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease (CVD).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
National Institute on Aging (NIA)
Collaborator:
Mead Johnson Nutrition
Treatments:
Estradiol
Estrogens